Moomoo AI 已提取核心信息
TC BioPharm has announced a General Meeting (GM) of shareholders to be held on March 14, 2024, at 2:00 p.m. UK time, at the company's registered office in Holytown, Motherwell. The meeting will address two ordinary resolutions: the authorization to adjourn the GM if necessary to permit further solicitation of proxies, and the authorization to issue securities in one or more non-public offerings in accordance with Nasdaq Marketplace Rule 5635(d). The latter is a strategic move to raise additional capital up to $4 million, which the company indicates is necessary to fund operations and implement its business strategy. The Board of Directors unanimously recommends shareholders vote in favor of the resolutions, emphasizing their alignment with the company's best interests. Shareholders registered by March 12, 2024, are entitled to vote, and those holding American Depositary Shares (ADSs) must submit their voting instructions by March 8, 2024. The GM notice includes detailed voting procedures and the Board's rationale for the proposed resolutions, highlighting the potential impact on the company's capital structure and governance.
TC BioPharm has announced a General Meeting (GM) of shareholders to be held on March 14, 2024, at 2:00 p.m. UK time, at the company's registered office in Holytown, Motherwell. The meeting will address two ordinary resolutions: the authorization to adjourn the GM if necessary to permit further solicitation of proxies, and the authorization to issue securities in one or more non-public offerings in accordance with Nasdaq Marketplace Rule 5635(d). The latter is a strategic move to raise additional capital up to $4 million, which the company indicates is necessary to fund operations and implement its business strategy. The Board of Directors unanimously recommends shareholders vote in favor of the resolutions, emphasizing their alignment with the company's best interests. Shareholders registered by March 12, 2024, are entitled to vote, and those holding American Depositary Shares (ADSs) must submit their voting instructions by March 8, 2024. The GM notice includes detailed voting procedures and the Board's rationale for the proposed resolutions, highlighting the potential impact on the company's capital structure and governance.
TC BioPharm宣布股东大会（GM）将于英国时间2024年3月14日下午2点在该公司位于马瑟韦尔霍利敦的注册办事处举行。会议将讨论两项普通决议：授权通用汽车在必要时休会以允许进一步征集代理人，以及授权根据纳斯达克市场规则5635（d）在一次或多次非公开发行中发行证券。后者是一项战略举措，旨在筹集高达400万美元的额外资金，该公司表示，这对于为运营提供资金和实施其业务战略是必要的。董事会一致建议股东对这些决议投赞成票，强调这些决议符合公司的最大利益。在2024年3月12日之前注册的股东有权投票，持有美国存托股份（ADS）的股东必须在2024年3月8日之前提交投票指示。通用汽车的通知包括详细的投票程序和董事会对拟议决议的理由，强调了对公司资本结构和治理的潜在影响。
TC BioPharm宣布股东大会（GM）将于英国时间2024年3月14日下午2点在该公司位于马瑟韦尔霍利敦的注册办事处举行。会议将讨论两项普通决议：授权通用汽车在必要时休会以允许进一步征集代理人，以及授权根据纳斯达克市场规则5635（d）在一次或多次非公开发行中发行证券。后者是一项战略举措，旨在筹集高达400万美元的额外资金，该公司表示，这对于为运营提供资金和实施其业务战略是必要的。董事会一致建议股东对这些决议投赞成票，强调这些决议符合公司的最大利益。在2024年3月12日之前注册的股东有权投票，持有美国存托股份（ADS）的股东必须在2024年3月8日之前提交投票指示。通用汽车的通知包括详细的投票程序和董事会对拟议决议的理由，强调了对公司资本结构和治理的潜在影响。
有用
没用